2022
DOI: 10.26226/m.62fa00996199da001930fc01
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

ESDR281 - Normalization of MCP1 and sCD40L after systemic treatment with bone marrow derived mesenchymal stromal cells correlated with clinical benefits in patients with recessive dystrophic epidermolysis bullosa

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles